Share
Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulat (in English)
The Law Library
(Author)
·
Createspace Independent Publishing Platform
· Paperback
Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulat (in English) - The Law Library
$ 15.92
$ 19.90
You save: $ 3.98
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Friday, July 05 and
Monday, July 08.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulat (in English)"
Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition) The Law Library presents the complete text of the Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition). Updated as of May 29, 2018 The Food and Drug Administration (FDA), after consultation with the Environmental Protection Agency (EPA), is amending FDA's regulation on the use of ozone-depleting substances (ODSs) in self-pressurized containers to remove the essential-use designation for epinephrine used in oral pressurized metered-dose inhalers (MDIs). The Clean Air Act requires FDA, in consultation with the EPA, to determine whether an FDA-regulated product that releases an ODS is an essential use of the ODS. FDA has concluded that there are no substantial technical barriers to formulating epinephrine as a product that does not release ODSs, and therefore epinephrine would no longer be an essential use of ODSs as of December 31, 2011. Epinephrine MDIs containing an ODS cannot be marketed after this date. This book contains: - The complete text of the Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition) - A table of contents with the page number of each section
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
